Multicenter Evaluation of Xpert Carba-R Assay for Detection and Identification of the Carbapenemase Genes in Rectal Swabs and Clinical Isolates

Doi, 2019, Treatment options for carbapenem-resistant gram-negative bacterial infections, Clin Infect Dis, 69, S565, 10.1093/cid/ciz830 Nordmann, 2013, Strategies for identification of carbapenemase-producing enterobacteriaceae, J Antimicrob Chemother, 68, 487, 10.1093/jac/dks426 Kitchel, 2009, Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258, Antimicrob Agents Chemother, 53, 3365, 10.1128/AAC.00126-09 Logan, 2017, The epidemiology of carbapenem-resistant enterobacteriaceae: the impact and evolution of a global menace, J Infect Dis, 215, S28, 10.1093/infdis/jiw282 Watanabe, 1991, Transferable imipenem resistance in Pseudomonas aeruginosa, Antimicrob Agents Chemother, 35, 147, 10.1128/AAC.35.1.147 Ruiz-Garbajosa, 2013, Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain, J Antimicrob Chemother, 68, 2487, 10.1093/jac/dkt237 Castanheira, 2013, Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineages, Microb Drug Resist, 19, 295, 10.1089/mdr.2012.0238 Kumarasamy, 2010, Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study, Lancet Infect Dis, 10, 597, 10.1016/S1473-3099(10)70143-2 Kazi, 2015, Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai, Eur J Clin Microbiol Infect Dis, 34, 467, 10.1007/s10096-014-2249-x Lee, 2016, Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods, Front Microbiol, 7, 1, 10.3389/fmicb.2016.00895 Zhang, 2017, Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae (CRE) strains in China, EBioMedicine, 19, 98, 10.1016/j.ebiom.2017.04.032 Kontopoulou, 2019, The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection, J Med Microbiol, 68, 326, 10.1099/jmm.0.000921 Schechner, 2013, Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?, Clin Microbiol Infect, 19, 451, 10.1111/j.1469-0691.2012.03888.x Dautzenberg, 2015, The association between colonization with carbapenemase-producing Enterobacteriaceae and overall ICU mortality: an observational cohort study, Crit Care Med, 43, 1170, 10.1097/CCM.0000000000001028 Mohan, 2017, Fecal carriage of carbapenem-resistant Enterobacteriaceae and risk factor analysis in hospitalised patients: a single centre study from India, Indian J Med Microbiol, 35, 555, 10.4103/ijmm.IJMM_17_144 Salomão, 2017, Carbapenem-resistant Enterobacteriaceae in patients admitted to the emergency department: prevalence, risk factors, and acquisition rate, J Hosp Infect, 97, 241, 10.1016/j.jhin.2017.08.012 Solgi, 2017, Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of blaNDM-7 and blaOXA-48, Eur J Clin Microbiol Infect Dis, 36, 2127, 10.1007/s10096-017-3035-3 Tamma, 2018, Phenotypic detection of carbapenemase-producing organisms from clinical isolates, J Clin Microbiol, 56, 1, 10.1128/JCM.01140-18 Nordmann, 2012, Identification and screening of carbapenemase-producing Enterobacteriaceae, Clin Microbiol Infect, 18, 432, 10.1111/j.1469-0691.2012.03815.x Miller, 2016, Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae, Expert Rev Anti Infect Ther, 14, 705, 10.1080/14787210.2016.1206815 Del Bianco, 2019, Comparison of four commercial screening assays for the detection of blakpc, blandm, blaimp, blavim, and blaoxa48 in rectal secretion collected by swabs, Microorganisms, 7, 704, 10.3390/microorganisms7120704 Baeza, 2019, Comparison of five methods for detection of carbapenemases in Enterobacterales with proposal of a new algorithm, Clin Microbiol Infect, 25, 1286.e9, 10.1016/j.cmi.2019.03.003 Lerner, 2013, Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant enterobacteriaceae, Antimicrob Agents Chemother, 57, 1474, 10.1128/AAC.01275-12 Tato, 2016, Multisite evaluation of cepheid xpert carba-r assay for detection of carbapenemase-producing organisms in rectal swabs, J Clin Microbiol, 54, 1814, 10.1128/JCM.00341-16 Traczewski, 2018, Multicenter evaluation of the xpert carba-R assay for detection of carbapenemase genes in gram-negative isolates, J Clin Microbiol, 56, 1, 10.1128/JCM.00272-18 Yang, 2016, Prevalence and fate of carbapenemase genes in a wastewater treatment plant in northern China, PLoS One, 11, e0156383, 10.1371/journal.pone.0156383 Lai, 2017, Molecular characterization of clinical IMP-producing Klebsiella pneumoniae isolates from a Chinese tertiary hospital, Ann Clin Microbiol Antimicrob, 16, 42, 10.1186/s12941-017-0218-9 Lafeuille, 2015, Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement, Int J Antimicrob Agents, 45, 441, 10.1016/j.ijantimicag.2014.12.009 Dortet, 2016, Improvement of the Xpert Carba-R Kit for the detection of carbapenemase-producing Enterobacteriaceae, Antimicrob Agents Chemother, 60, 3832, 10.1128/AAC.00517-16 Mittal, 2016, Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India, BMC Microbiol, 16, 1, 10.1186/s12866-016-0763-y Wang, 2018, Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE study in China (2012-2016), Clin Infect Dis, 67, S196, 10.1093/cid/ciy660 PÉrez-VÁzquez, 2020, Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2, Int J Antimicrob Agents, 56, 106026, 10.1016/j.ijantimicag.2020.106026 Torrens, 2016, Activity of ceftazidime-avibactam against clinical and isogenic laboratory Pseudomonas aeruginosa isolates expressing combinations of most relevant β-lactam resistance mechanisms, Antimicrob Agents Chemother, 60, 6407, 10.1128/AAC.01282-16 Kresken, 2020, Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany, Int J Antimicrob Agents, 55, 105959, 10.1016/j.ijantimicag.2020.105959 Hsu, 2017, Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia, Clin Microbiol Rev, 30, 1, 10.1128/CMR.00042-16 Bonomo, 2018, Carbapenemase-producing organisms: a global scourge, Clin Infect Dis, 66, 1290, 10.1093/cid/cix893 van Duin, 2018, Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae, Clin Infect Dis, 66, 163, 10.1093/cid/cix783 de Jonge, 2016, In vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible Enterobacteriaceae isolates collected during the INFORM global surveillance study (2012 to 2014), Antimicrob Agents Chemother, 60, 3163, 10.1128/AAC.03042-15 Zhou, 2019, Active surveillance of carbapenemase-producing organisms (CPO) colonization with Xpert Carba-R assay plus positive patient isolation proves to be effective in CPO containment, Front Cell Infect Microbiol, 9, 162, 10.3389/fcimb.2019.00162